PULMONARY-FUNCTION AND SYMPTOM RESPONSES AFTER 6.6-HOUR EXPOSURE TO 0.12 PPM OZONE WITH MODERATE EXERCISE
PULMONARY-FUNCTION AND SYMPTOM RESPONSES AFTER 6.6-HOUR EXPOSURE TO 0.12 PPM OZONE WITH MODERATE EXERCISE
复制标题
DOI:
10.1080/08940630.1988.10466349
复制
发表时间:
1988-01-01
期刊:
影响因子:
--
通讯作者:
HORSTMAN, DH
中科院分区:
文献类型:
--
作者:
FOLINSBEE, LJ;MCDONNELL, WF;HORSTMAN, DH
Episodes occasionally occur when ambient ozone (O3) levels remain at or near 0.12 ppm for more than 6 h. Small decrements in lung function have been reported following 2-h exposures to 0.12 ppm O3. For short exposures to higher O3 concentrations, lung function decrements are a function of exposure duration. Thus, we investigated the hypothesis that prolonged exposure to 0.12 ppm O3 would result in progressively larger changes in respiratory function and symptoms over time. Ten nonsmoking males (18-33 yr) were exposed once to clean air and once to 0.12 ppm O3 for 6.6 h. Exposures consisted of six 50-min exercise periods, each followed by 10-min rest and measurement; a 35-min lunch period followed the third exercise period. Exercise ventilation averaged approximately 40 L/min. Forced expiratory and inspiratory spirometry and respiratory symptoms were measured prior to exposure and after each exercise. Airway reactivity to methacholine was determined after each exposure. After correcting for the air exposures, FEV 1.0 was found to decrease linearly during the O3 exposure and was decreased by an average of 13.0 percent (591 mL) at the end of exposure. Decreases in FVC and FEF25-75% were also linear and averaged 8.3 and 17.4 percent, respectively, at the end of exposure. On forced inspiratory tests, the FIVC and FIVO5 were decreased 12.6 and 20.7 percent, respectively. Increases in the symptom ratings of cough and pain on deep inspiration were observed with O3 exposure but not with clean air. Airway reactivity to methacholine was approximately doubled following O3 exposure. We conclude that prolonged exposure to 0.12 ppm O3 results in progressive changes in respiratory function, a marked increase in nonspecific airway reactivity, and progressive changes in symptoms.